Clinical Grade Non-Transfusable Mobilized Peripheral Blood CD62L+ Cells, Plerixafor, Frozen
CD62L, also known as L-selectin, is expressed on a wide range of peripheral blood cells including B cells, T cells, monocytes, and granulocytes, to name a few.
Human mobilized peripheral blood CD62L+ cells are enriched from the total cell population using direct immunomagnetic anti-CD62L beads. All cell isolation components, including reagents, tubing sets, instruments, and buffers, are manufactured and controlled under an ISO 13485 certified quality system under FDA oversight. Cell culture procedures, including open manipulation of vials, final filling, and closure of finished products, are performed inside ISO 5 air quality processing chambers located within an FDA-registered cell manufacturing facility. Isolated primary cells are characterized by flow cytometry to ensure a highly pure and viable cell population.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols. All reagents and devices used to collect and separate the cells are certified clinical grade. This item is for research use only.
|Cell and Tissue Source||Peripheral Blood|
|Product Type||Primary Cells|
|Cell Type||T Cells|
|Donor Attributes||HIV-, HepB-, HepC-|
|Purity||≥85% by Flow Cytometry|
|Viability||≥70% by Flow Cytometry|
|Contains||CryoStor™ CS10 (10% DMSO)|
|Injections||240μg/kg Plerixafor the day before collection|